Health Catalyst, Inc.
HCAT
$1.10
-$0.12-9.50%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 74.68M | 76.32M | 80.72M | 79.41M | 79.61M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 74.68M | 76.32M | 80.72M | 79.41M | 79.61M |
| Cost of Revenue | 35.29M | 37.39M | 42.25M | 41.59M | 44.74M |
| Gross Profit | 39.39M | 38.94M | 38.48M | 37.83M | 34.87M |
| SG&A Expenses | 19.85M | 23.07M | 25.49M | 25.74M | 22.86M |
| Depreciation & Amortization | 12.88M | 12.61M | 12.68M | 12.32M | 10.27M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 77.88M | 83.98M | 92.38M | 93.00M | 92.77M |
| Operating Income | -3.20M | -7.65M | -11.66M | -13.58M | -13.17M |
| Income Before Tax | -90.65M | -22.19M | -40.90M | -23.53M | -20.05M |
| Income Tax Expenses | 379.00K | 41.00K | 81.00K | 215.00K | 625.00K |
| Earnings from Continuing Operations | -91.03M | -22.23M | -40.98M | -23.74M | -20.67M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -91.03M | -22.23M | -40.98M | -23.74M | -20.67M |
| EBIT | -3.20M | -7.65M | -11.66M | -13.58M | -13.17M |
| EBITDA | 6.28M | 1.76M | -1.98M | -4.16M | -5.40M |
| EPS Basic | -1.28 | -0.32 | -0.59 | -0.35 | -0.33 |
| Normalized Basic EPS | -0.07 | -0.11 | -0.14 | -0.15 | -0.16 |
| EPS Diluted | -1.28 | -0.32 | -0.59 | -0.35 | -0.33 |
| Normalized Diluted EPS | -0.07 | -0.11 | -0.14 | -0.15 | -0.16 |
| Average Basic Shares Outstanding | 71.00M | 70.38M | 69.63M | 68.55M | 62.38M |
| Average Diluted Shares Outstanding | 71.00M | 70.38M | 69.63M | 68.55M | 62.38M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |